ASX - By Stock
|
FEX |
Re:
Ann: Quarterly Cashflow Report
|
|
Slips7
|
145 |
45K |
1 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
145
|
45K
|
1
|
|
ASX - By Stock
|
BSX |
Re:
Ann: Kingsnake adds to Blackstone Massive Sulfide Nickel Strategy
|
|
Slips7
|
115 |
33K |
2 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
115
|
33K
|
2
|
|
ASX - By Stock
|
BSX |
Re:
BSX Day to Day SP discussion
|
|
Slips7
|
4.6K |
1.2M |
5 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
4.6K
|
1.2M
|
5
|
|
ASX - By Stock
|
ALA |
Re:
Suda 50c (150 million MC)
|
|
Slips7
|
49 |
14K |
2 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
49
|
14K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
851,922
|
|
Slips7
|
2 |
1.0K |
2 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
2
|
1.0K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Australian Biomarker Patent Allowed
|
|
Slips7
|
6 |
2.0K |
4 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
6
|
2.0K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
breakout imminent
|
|
Slips7
|
15 |
6.0K |
3 |
28/09/20 |
28/09/20 |
ASX - By Stock
|
15
|
6.0K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
breakout imminent
|
|
Slips7
|
15 |
6.0K |
2 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
15
|
6.0K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: US Patent for Sygenus
|
|
Slips7
|
19 |
4.8K |
5 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
19
|
4.8K
|
5
|
|
ASX - By Stock
|
AR9 |
Re:
Ann: Appendix 4C - quarterly
|
|
Slips7
|
392 |
135K |
2 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
392
|
135K
|
2
|
|
ASX - By Stock
|
WHK |
Re:
Future potential
|
|
Slips7
|
2 |
1.1K |
5 |
30/07/20 |
30/07/20 |
ASX - By Stock
|
2
|
1.1K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: FDA Orphan Drug Designation - Idiopathic Pulmonary Fibrosis
|
|
Slips7
|
13 |
5.8K |
4 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
13
|
5.8K
|
4
|
|
ASX - By Stock
|
OLL |
Re:
Ann: Full Year Statutory Accounts
|
|
Slips7
|
5 |
2.8K |
6 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
5
|
2.8K
|
6
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Q3 Investor Presentation COVID-19
|
|
Slips7
|
67 |
21K |
2 |
26/03/20 |
26/03/20 |
ASX - By Stock
|
67
|
21K
|
2
|
|
ASX - By Stock
|
UCM |
Re:
UCM in the AFR
|
|
Slips7
|
362 |
2.8M |
5 |
22/03/20 |
22/03/20 |
ASX - By Stock
|
362
|
2.8M
|
5
|
|
ASX - By Stock
|
OLL |
Re:
Canaccord BUY Rating
|
|
Slips7
|
5 |
3.3K |
3 |
15/03/20 |
15/03/20 |
ASX - By Stock
|
5
|
3.3K
|
3
|
|
ASX - By Stock
|
ELS |
Elsight and Monogoto
|
|
Slips7
|
0 |
460 |
4 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
0
|
460
|
4
|
|